Kestra Advisory Services’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $721K | Buy |
|
|||||
|
2025
Q1 | $591K | Sell |
|
|||||
|
2024
Q4 | $980K | Buy |
|
|||||
|
2024
Q3 | $685K | Sell |
|
|||||
|
2024
Q2 | $638K | Buy |
|
|||||
|
2024
Q1 | $559K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $90.7K | Sell |
|
|||||
|
2022
Q4 | $186K | Buy |
|
|||||
|
2022
Q3 | $121K | Sell |
|
|||||
|
2022
Q2 | $300K | Buy |
|
|||||
|
2022
Q1 | $97K | Sell |
|
|||||
|
2021
Q4 | $103K | Buy |
|
|||||
|
2021
Q3 | $118K | Buy |
|
|||||
|
2021
Q2 | $105K | Sell |
|
|||||
|
2021
Q1 | $206K | Sell |
|
|||||
|
2020
Q4 | $517K | Buy |
|
|||||
|
2020
Q3 | $327K | Buy |
|